================================================================================

[PORTIONS OF THIS EXHIBIT HAVE BEEN REDACTED PURSUANT TO A REQUEST FOR
CONFIDENTIAL TREATMENT AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE
COMMISSION.]

                                  APPENDIX A-8

                                    PRODUCTS


Product Name:     Denise Austin Pilates  - AB-108N

Product Description: Yoga Trainer Product

Projected Units Sold next 24 months: XXXXXX

Manufacturer:     CirTran-Asia

Sub-Manufacturer: Zhejiang Hengtai Machinary Manufacturing Co., Ltd

Marketing Partner Contact Info:     Tri-Star


Current Sale Price: $XXXXXX USD - CIRTRAN-ASIA

Current Cost to Manufacturer:       $XXXXXX USD

Total Tooling/Development Costs:    $20,000 USD

Gross Profit Margin Per Unit - $XXXXXX

CirTran-Asia               $ 0.30 USD
Charles Ho                 $ 0.95 USD

Denise Austin Pilates Stock Option Schedule

Upon full execution of this Agreement, Cirtran's parent CirTran Corporation will
issue the following options to purchase restricted common stock:

                  Charles Ho                500,000 shares

These initial options will vest and be exercisable only after Cirtran has sold
200,000 Denise Austin Pilates units. The options will be exercisable at $.06 per
share after vesting. The options will expire and will no longer be exercisable
on the date one year after the date hereof.

In addition, for each whole multiple of 100,000 Denise Austin Pilates units sold
by Cirtran during the first 24 months of this Agreement in excess of the initial
200,000 units, CirTran Corporation will grant Charles Ho an option to purchase
100,000 shares. Each such additional option will be exercisable for a period of
12 months at an exercise price equal to the fair market value of CirTran
Corporation stock on the date of grant (i.e. the mean between the high bid and
low asked prices for the stock for the date of determination).



As a condition to grant of the options, each option holder will be required to
make standard investment representations to CirTran Corporation.

[XXXXX - REDACTED PURSUANT TO REQUEST FOR CONFIDENTIAL TREATMENT FILED WITH THE
SECURITIES AND EXCHANGE COMMISSION.]



--------------------------------------------------------------------------------